Siavash Atrchian

Treatment With Stereotactic Ablative Radiotherapy for Up to 5 Oligometastases in Patients With Cancer

Robert Olson, Will Jiang, Mitchell Liu et al. · JAMA Oncology · 2022 · 69 citations · Full text

Medicine, Oncology, Radiation Oncology +13

Progression-Free Survival and Local Control After SABR for up to 5 Oligometastases: An Analysis From the Population-Based Phase 2 SABR-5 Trial

Sarah Baker, Will Jiang, Benjamin Mou et al. · International Journal of Radiation Oncology*Biology*Physics · 2022 · 43 citations

Medicine, Oncology, Molecular Oncology +5

Training and Validation of Deep Learning-Based Auto-Segmentation Models for Lung Stereotactic Ablative Radiotherapy Using Retrospective Radiotherapy Planning Contours

Jordan Wong, Vicky Huang, Joshua Giambattista et al. · Frontiers in Oncology · 2021 · 31 citations · Full text

Medicine, Radiation Oncology, Radiology +17

Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? a secondary analysis of the population-based phase II SABR-5 trial

Reno Eufemon Cereno, Benjamin Mou, Sarah Baker et al. · Radiotherapy and Oncology · 2023 · 28 citations

Medicine, Oncology, Radiation Oncology +17

Validation of the Prognostic Utility of ESTRO/EORTC Oligometastatic Disease Classification: A Secondary Analysis From the Population-Based Phase II SABR-5 Trial

Sarah Baker, Benjamin Mou, W. Jiang et al. · International Journal of Radiation Oncology*Biology*Physics · 2022 · 22 citations

Dentistry, Oncology, Clinical Classification Systems +9